Outcomes of venous thromboembolism care: future directions
- PMID: 36863565
- DOI: 10.1016/j.jtha.2023.02.015
Outcomes of venous thromboembolism care: future directions
Abstract
The complete picture of the outcomes of venous thromboembolism (VTE) care consists of conventional binary clinical outcomes (death, recurrent VTE, and bleeding), patient-centered outcomes, and society-level outcomes. Combined, these allow for the introduction of outcome-driven patient-centered health care. The emerging concept of valuing health care from such a holistic point of view, ie, value-based health care, holds a huge potential to revolutionize-and improve-the organization and evaluation of care. The ultimate goal of this approach was to achieve a high value for patients, ie, the best possible clinical outcomes at the right cost, providing a framework for evaluation and comparisons of different management strategies, patient pathways, or even complete health care delivery systems. To facilitate this, outcomes of care from a patient perspective, such as symptom burden, functional limitations, and quality of life, need to be routinely captured in clinical practice and trials, complementary to the conventional clinical outcomes, to fully capture the patients' values and needs. The aim of this review was to discuss the relevant outcomes of VTE care, explore value in VTE care from different perspectives, and propose future directions to inspire change. This is a call to action to shift the focus to outcomes that matter and make a larger difference in the lives of patients.
Keywords: outcome assessment; patient-centered care; patient-reported outcomes; value-based health care; venous thromboembolism.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interests F.A.K. reports grants or contracts from Bayer, BMS, BSCI, MSD, Leo Pharma, Actelion, Pharm-X, The Netherlands Organisation for Health Research and Development, the Dutch Thrombosis Association, The Dutch Heart Foundation, and the Horizon Europe Program, all unrelated to this work and paid to his institution. R.P.R. reports research grants to her institution from BMS and Janssen; consultant/advisory board to Abbott, BMS, Dova, Inari, and Penumbra, and the National Lead Investigator for Storm-PE, Penumbra. All DOIs are outside and unrelated to the scope of this work. C.M.M.dJ. reported no conflicts of interest related to this project.
Publication types
MeSH terms
LinkOut - more resources
Miscellaneous